Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Asset Writedowns and Impairment (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $2.7 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Asset Writedowns and Impairment fell 68.47% year-over-year to $2.7 million, compared with a TTM value of $11.3 million through Jun 2025, up 33.0%, and an annual FY2023 reading of -$474000.0, down 126.2% over the prior year.
  • Asset Writedowns and Impairment was $2.7 million for Q2 2025 at SRx Health Solutions, up from $43000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $8.5 million in Q2 2024 and bottomed at -$682000.0 in Q1 2023.
  • Average Asset Writedowns and Impairment over 4 years is $961000.0, with a median of $135000.0 recorded in 2023.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 407.21% in 2023, then surged 6220.0% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $1.3 million in 2022, then tumbled by 60.48% to $513000.0 in 2023, then plummeted by 96.88% to $16000.0 in 2024, then soared by 16712.5% to $2.7 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for SRXH at $2.7 million in Q2 2025, $43000.0 in Q1 2025, and $16000.0 in Q3 2024.